Omniab earnings were -$61.3M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest OABI earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$18.2M, up 39.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, OABI reported annual earnings of -$62.0M, with 22.5% growth.
On OABI's earnings call on Invalid Date, Omniab (NASDAQ: OABI) reported Q1 2025 earnings per share (EPS) of -$0.17, up 10.53% year over year. Total OABI earnings for the quarter were -$18.20 million. In the same quarter last year, Omniab's earnings per share (EPS) was -$0.19.
As of the last Omniab earnings report, Omniab is currently losing money. Omniab's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$61.27 million, a 3.48% decrease year over year.
What was OABI's earnings growth in the past year?
As of Omniab's earnings date in Invalid Date, Omniab's earnings has grown year over year. OABI earnings in the past year totalled -$61.27 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.